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Introduction
A basic property of living systems is the ability to respond to 
extracellular signals by evoking an internal response, which 
often leads to changes in gene expression and phenotypic 
alterations. Synthetically modifying an organism to respond 
differently to a signal, or to respond to an artificial signal, is 
accomplished through rewiring existing pathways or adding 
new modules that in some cases may be a complete path-
way (for instance, the transplantation of a pathway to another 
cell type or species). The two main objectives of engineering 
signaling pathways are to understand how natural networks 
function and to build synthetic networks with specific applica-
tions or functionalities. Progress in this field may have a major 
impact on biomedical engineering, such as gene therapy or 
tissue engineering, and industrial biotechnology.
Synthetic biology has naturally evolved as a field in bio-
technology that has a broader engineering scope: to modify 
entire systems. This would not have been possible without the 
development of systems biology, which has benefited tremen-
dously from high-throughput technologies (DNA microarrays, 
ultrasequencing, mass spectrometry, automated microscopy, 
and computation). Initially, synthetic biology focused on the 
engineering of genetic circuits, which were first designed to 
study negative and positive feedback loops, oscillations, 
noise, and robustness within a system (Becskei and Serrano, 
2000; Becskei et al., 2001; Elowitz and Leibler, 2000; Gardner 
et al., 2000; Fung et al., 2005; Swinburne et al., 2008). Later, 
gene circuits were designed to couple gene expression with 
metabolism, to understand quorum-sensing pathways (Bulter 
et al., 2004; Balagaddé et al., 2008), and to synthesize new 
chemical compounds (for example, the production of terpe-
noids in engineered Escherichia coli; see Martin et al., 2003). 
They have also been used to study memory (Friedland et al., 
2009), spatial patterning (Basu et al., 2005), and network evolu-
tion (Isalan et al., 2008).
The design of synthetic circuits in eukaryotes began with the 
accessibility of a wide range of molecular tools (many coming 
from work in bacterial engineering, such as inducible expres-
sion systems; reviewed in Gossen and Bujard, 2002), which 
have since evolved tremendously in terms of their complexity. 
For example, the design of an inducible gene silencing mod-
ule based on RNA interference and repressor proteins (Deans 
et al., 2007) as well as the first tunable synthetic mammalian 
oscillator in hamster ovary cells (CHO) and human embryonic 
kidney (HEK293) cells (Tigges et al., 2009) have recently been 
reported. Several recent reviews have covered the engineering 
of synthetic gene circuits (see Dueber et al., 2004; Andrianan-
toandro et al., 2006; Drubin et al., 2007; Greber and Fusseneg-
ger 2007; Serrano, 2007; Michalodimitrakis and Isalan, 2009). 
However, not covered in these reviews is a detailed analysis of 
the challenges and differences of engineering gene circuits as 
compared to signaling systems, and when using prokaryotic 
versus eukaryotic cells.
The aim of this review is to address these two features of 
synthetic biology. The first part describes the conceptual dif-
ferences between engineering signaling pathways as com-
pared to genetic circuits. We highlight the different properties 
of the components and the general properties of the circuits. 
In the second part, we compare signaling pathway engineering 
in prokaryotes as opposed to eukaryotes, contrasting the dif-
ferences in architecture and components of these two classes 
of systems and how these differences impose different design 
considerations. This is complemented by reviewing examples 
of pioneering and the latest engineering approaches. The 
review concludes with our perspective on how the field might 
evolve and what remaining challenges are left to be faced.
Engineering of Gene Circuits versus Signaling Pathways
What are the differences and what should be considered when 
engineering signal transduction pathways as opposed to gene 
circuits? There are two main points to consider, one being the 
general properties of the system and the other being its compo-
nents (Figure 1). Regarding the general properties of the system: 
(1) Signaling pathways operate fast (milliseconds to minutes). 
In contrast, transcriptional responses can range from minutes 
(prokaryotes) to hours (eukaryotes) (see the recent review by 
Pryciak, 2009) (although expression changes might be faster 
if the system involves noncoding RNA, as it would not require 
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nuclear export and translation. (2) Signal transduction pathways 
usually depend on subcellular localization, and therefore elicit 
spatially restricted, context-specific responses. (3) Operations 
at the level of protein activity, unlike protein levels, allow for a 
larger degree of control and tuning capability. Thus, engineering 
signal transduction pathways could allow for more versatility and 
design options, but the predictability of the engineered pathway, 
at least in eukaryotes, could be low because of the complexity of 
signal propagation and the greater number of different molecules 
involved. (4) Genetic circuits tend to be noisy because mRNA 
and protein synthesis occur in bursts and are the major source 
of biological noise (Pedraza and Paulsson, 2008), whereas sig-
naling pathways usually involve larger number of molecules and 
thus tend to be less stochastic. (5) Signaling systems employing 
amplification cascades need to avoid spontaneous activation, 
which is usually achieved by negative feedback regulation (such 
as in epidermal growth factor signaling; see Amit et al., 2007) 
and also in many cases by the requirement of a double trigger-
ing signal (as in B cell signaling; reviewed in Kurosaki, 2002).
Regarding the components of the two systems, there are 
some fundamental differences (Figure 1): (1) Gene circuit 
engineering is done on the level of DNA and DNA binding 
proteins. DNA is easy to modify, given that it has a modular 
structure and nucleotides can be exchanged without hav-
ing a large impact on DNA structure (Benner and Sismour, 
2005). Therefore, placement of DNA sequences where they 
can be recognized by DNA binding proteins in regulatory 
regions of a gene is, in principle, relatively easy in prokary-
otes or, when plasmids are used, in eukaryotes. However, 
when inserting a construct in eukaryotic chromosomes, one 
needs to consider context effects (such as heterochromatin 
versus euchromatin, and epigenetic regulation). On the other 
hand, there have been some advances for DNA binding pro-
teins, in rationally modifying their DNA binding specificities 
(Ashworth et al., 2006; Redondo et al., 2008), but this is not 
yet a well-established methodology. However, engineering 
DNA binding can be greatly facilitated by taking advantage 
of the extensive work on modular zinc-finger proteins to cre-
ate transcription factors with new DNA binding specificities 
(Townsend et al., 2009). (2) Engineering of signal transduc-
tion networks requires the modification of proteins alone, or 
protein-protein interactions, either by mutagenesis, inser-
tion of unstructured recognition sequences, or alteration of 
domain composition. Although in some cases polypeptides 
(linear motifs) can be exchanged as easily as DNA modules, 
introduction of mutations inside domains or globular proteins 
is more complicated given that the conformation of an amino 
acid side chain greatly depends on the conformation of its 
neighboring residues and vice versa. As a consequence, their 
replacement could cause structural changes that can lead to 
protein misfolding and aggregation (López De La Paz et al., 
2002; Chiti and Dobson, 2006). Thus, manipulating DNA can 
often be done without compromising its structural compo-
sition and the function of the various components, whereas 
manipulating proteins requires the use of protein design tools 
(Dahiyat, 2006), or a combination of directed evolution with 
selection (Looger et al., 2003).
In summary, the three main differences between engineering 
signal transduction as opposed to gene circuits are as follows: 
(1) signaling systems operate fast, and thus designing inter-
connections and feedbacks requires accurate prediction of the 
system behavior, (2) subcellular localization plays an important 
role in signaling and must be considered, and (3) engineering 
of proteins is more difficult than DNA because protein structure 
and folding is less understood and less predictable.
Hence, the main challenges in engineering genetic systems 
are (1) coping with the inherent stochasticity of transcription-
translation (in prokaryotes this can be diminished by engi-
neering negative feedback of the transcription factors on their 
own promoters), (2) generating enough variants of selected 
DNA binding proteins to ensure recognition of almost all DNA 
sequences, (3) finding more transcription factors that can be 
modulated by chemical compounds (for example, the TET 
repressor), or postranslational modifications, to ensure a high 
dynamic range of regulation and the possibility of combining 
more than one transcription factors, (4) getting a better grasp 
of the regulatory role of chromatin structure in eukaryotes and 
possibly in prokaryotes, (5) incorporating other regulatory mol-
ecules (such as riboswitches and small RNAs), and (6) taking 
advantage of the possibility of playing with the histone code.
Figure 1. The Engineering of Signal Transduction Pathways and 
Gene Networks
When engineering signal transduction pathways as opposed to gene circuits, 
there are two main points to consider: the general properties of the system 
and its components. Regarding the components, nucleotides can usually be 
exchanged without having a large impact on neighbor nucleotides and DNA 
structure (“independence approximation”). In contrast, amino acid substitu-
tions in proteins can lead to structural changes and misfolding. With respect 
to the circuit properties, gene circuits are modular, they usually respond slow-
ly, and the responses can be stochastic. In contrast, signaling pathways are 
highy modular, respond fast, often involve signal amplication, and make use 
of spatial localization.
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Tools for Signaling Pathway Engineering
Signal transduction relies on a series of mechanisms, which 
to some degree are conserved in both prokaryotes and 
eukaryotes (Table 1). Essentially, they include all or some of 
the following mechanisms: localization, complex assembly, 
competition, activation-deactivation, diffusion and/or active 
transport, modularity, degradation, negative and positive 
feedbacks, specificity, and crosstalk (reviewed in Teruel and 
Meyer, 2000; Jordan et al., 2000; Aravind et al., 2003; Galp-
erin, 2004; Galperin and Gomelsky, 2005). Thus, in order to 
design or modify signal transduction pathways, one could 
tackle any of the characteristics above. Depending on which 
segment of the pathway one would like to target, different 
tools can be employed (Figure 2). Below, we will describe 
both the design tools that have been used already (some 
examples are highlighted in the next section) and those 
that are available but have not yet been tested in synthetic 
approaches. In every case, we will point out the peculiarities 
of prokaryotes and eukaryotes that could constrain the use 
of particular tools.
Localization
As signal transduction pathways in eukaryotes are often spa-
tially restricted, modifying the location of proteins is a power-
ful tool for rewiring a pathway. A protein can be retargeted 
by using scaffold proteins that recognize a protein domain, 
adaptor proteins, or lipids (Harris et al., 2001; Park et al., 
2003; Bashor et al., 2008), as well as by introducing post-
translational modifications recognized by other proteins or by 
the membrane (for instance, lipid anchoring; see Kamalak-
kannan et al., 2004). Another tool for rewiring signal trans-
duction routes by localization in single cells is the spatially 
restricted expression of proteins using localized transfection, 
Table 1. Comparing Signal Transduction in Prokaryotes and Eukaryotes
Prokaryotes Eukaryotes
Mechanism of Signal Transduction
Phosphorrelay
 One-component systems yes no
 Two-component systems yes yes (only in yeast and plants)
Kinases and phosphatases
 Histidine-Aspartic acid phosphotransfer yes (mainly) yes (rare)
 Serine/threonine kinases yes (rare) yes (mainly)
 Tyrosine kinases yes (rare) yes (not in plants, rare in yeast)
Other posttranslational modification (such as 
 methylation, acetylation)
yes yes
Second messengers and alarmones
 Nucleotide derivatives yes yes
 Lipids no yes
Allosteric regulation yes yes
Modularity
 Multidomains fewer majority
 Autoinhibition yes yes
 Anchoring yes yes
Complex formation
 Oligomerization yes yes
 Receptor clustering yes yes
Proteolysis and degradation yes yes (complex regulation)
Network Properties
Active transport yes (simple) yes (complex)
Pathway length short long cascades
Regulation by localization
 Subcellular localization yes yes
 Scaffolds poorly studied yes
 Gradients unknown important
Regulation by scaffolds yes (but not well established) yes
Noise resistance/robustness yes, often required for function yes
Negative and positive feedback regulation yes (mainly transcriptional) yes, important (mainly at protein level)
Crosstalk between pathways yes (rare, and physiological  relevance often 
unknown)
yes (very important)
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or using the localized application of a stimulus with magnetic 
beads (Kempiak and Segall, 2004; Isalan et al., 2005; Santori 
et al., 2006). Furthermore, there is the possibility of changing 
localization with bifunctional small molecules. Using the so 
called “anchor-away technique” (in the yeast Saccharomyces 
cerevisiae), a protein of interest, which is shuttling between 
the nucleus and cytosol, is depleted from the nucleus and 
consequently becomes associated to an anchor membrane 
protein (Haruki et al., 2008).
Subcellular localization exists in prokaryotes as well, with 
receptor clustering and signaling protein enrichment in cell 
poles being critical in bacteria chemotaxis (see Porter et al., 
2008) as well as for cell division and differentiation (reviewed in 
Jenal and Stephens, 2002). However, in general, there are no 
isolated compartments, and therefore the number of localiza-
tions and the possibilities of using localization to engineer sig-
naling in bacteria are greatly reduced. In prokaryotes, the lack 
of knowledge of how to restrict proteins to particular regions of 
the membrane and the lack of compartments makes this dif-
ficult. Recent advances in understanding the role that positive 
membrane curvature plays in selective localization of bacte-
rial proteins at the poles, as well as a growing list of bacterial 
proteins that exhibit specific membrane compartmentalization 
(Ramamurthi and Losick, 2009), could open the way for using 
localization as a tool in bacteria.
Complex Assembly and Dynamics
Signaling requires the transient assembly of protein complexes, 
which in many cases results in a restricted conformational flex-
ibility of the proteins involved, as well as in the conformational 
changes that affect protein function. Altering the affinities and 
the kinetics of complex formation (dynamics), as well as creat-
ing artificial binding sites (complex assembly), can be a power-
ful way of modifying or changing signal transduction pathways 
in a rational manner.
Mutagenesis, either driven by computer design or by 
directed evolution, can be used to alter the specificity and the 
affinity of an interaction (in eukaryotes, see Reina et al., 2002, 
and Kortemme et al., 2004; in bacteria, see Lyon et al., 2000, 
and Looger et al., 2003) as well as the kinetics of complex for-
mation (Selzer et al., 2000; Kiel et al., 2004). Recent advances 
in protein design suggest that this is achievable, provided that 
a high-resolution structure of the protein-protein or protein-
DNA complex is available (see Aloy et al., 2004, and Dahiyat, 
2006; reviewed in Kiel et al., 2008). The main limitations at the 
moment are the capability of both predicting and engineering 
large conformational changes upon interaction, as well as the 
changes in the dynamics and flexibility of regions of a protein 
upon interaction with another. Future developments in protein 
design tools, which could tackle the above, will pave the way 
for using changes in protein flexibility and conformational rear-
rangements for engineering signaling pathways.
Posttranslational modifications, such as phosphorylation, 
allow the possibility of modifying the assembly of protein com-
plexes. For example, introducing a target site for a kinase can 
create binding sites for proteins that contain SH2 domains 
(which bind phosphorylated tyrosines), thereby influencing the 
assembly of its complexes and spatially restricting them (Due-
ber et al., 2003). In this case, the challenge is to know whether 
the kinase recognition motif is sufficient for bringing two pro-
teins together or whether additional recognition is needed from 
other domains or scaffolds to ensure that the proteins colocal-
ize in the cell. This is especially important in eukaryotic cells.
Modularity
The association of functional domains within a single polypep-
tide chain is not exclusive in every domain of life. Although pro-
tein modularity is present along the tree of life, the complexity 
of domain composition and the variety of protein folds is larger 
Figure 2. Signaling Pathway Engineering in Prokaryotes and 
 Eukaryotes
Signal transduction can be engineered on three different levels, illustrated 
here using three examples: (1) pathway modulation, for example by protein 
mutagenesis, (2) the rewiring of existing pathways, which can be achieved by 
creating chimeric proteins that have new input-output domains, and (3) the 
creation of artificial signal transduction pathways and cells.
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in nucleated organisms (Aravind et al., 2003), with multiple 
domains having weak binding affinities present in one protein. 
In addition, the average protein length is larger in eukaryotes, 
(Brocchieri and Karlin, 2005). This provides a greater flexibility 
in engineering signal transduction pathways in eukaryotes, as 
it is possible to replace or add modules in proteins to change 
their binding partners and localizations (Dueber et al., 2003; 
Haruki et al., 2008). Of course, this is not trivial. Even if domains 
fold autonomously, domains can change, and unfold the struc-
ture of the full-length protein into which they are inserted. Such 
approaches often require several steps of domain optimiza-
tion. These domain prediction and optimization steps can 
be supported by prediction programs, like SMART, Pfam, or 
InterPro (Finn et al., 2008; Letunic et al., 2009; Hunter et al., 
2009). If folding problems persist when placing two domains 
on a single chain, another option is to express the domains 
separately in fusion with dimerization motifs, such as leucine 
zippers (Rieker and Hu, 2000), so that they fold independently. 
Although in principle one could design more complex and ver-
satile, multidomain proteins in bacteria, the question remains 
whether such large polypeptides will be correctly folded and 
functional, because of the lack of folding machinery to cope 
with such large multidomain proteins (Seeliger et al., 2005). In 
the future, a database collection of protein domains that have 
been shown to fold robustly and to tolerate fusion to other 
domains could help enormously in the engineering of new mul-
tidomain proteins. In this respect, help may come from initia-
tives like the Biobricks repository (http://www.biobricks.org/) 
(Shetty et al., 2008), which plans to have a large collection of 
protein domains experimentally tested as building blocks.
Activation-Deactivation
A key characteristic of signal transduction is the need to acti-
vate components for only a brief period of time followed by 
deactivation. Activation can be done by binding chemical mes-
sengers or ions, or by posttranslational modifications (such as 
phosphorylation, acetylation, and methylation). Deactivation 
involves degradation of the chemical messengers, seques-
tration of the ions, or reversal of the respective posttransla-
tional modifications. It is important to mention that many signal 
transduction proteins are regulated by autoinhibition: a part of 
the protein binds to or changes the conformation of its own 
active site, thereby inhibiting its activity. This property has 
been used by different investigators to regulate engineered 
networks (reviewed in Pryciak, 2009). Autoinhibition can be 
released by a competitive ligand or posttranslational modifi-
cation (reviewed in Bhattacharyya et al., 2006). Other groups 
also have replaced small molecule activators (such as Ca2+, 
cAMP, and phosphoinositides), by drugs activating the cor-
responding enzyme (such as forskolin, for cAMP), giving an 
additional level of external control (Metzger and Lindner, 1981). 
Recently, a new generation of synthetic modulators, namely 
bifunctional small molecules (see Corson et al., 2008), have 
been designed with the ability to act as bridges between two 
domains or proteins, giving rise to different biological effects, 
such as receptor activation in the absence of its ligand (useful 
for orphan receptors) or changing activity via subcellular tar-
geting (Spencer et al., 1993; Belshaw et al., 1996; Rivera et al., 
1996). Furthermore, we would like to mention tools to control 
phosphorylation in a light-dependent manner through the use 
of chimaeras of photoreceptors and kinases (Levskaya et al., 
2005; Airan et al., 2009), as well as regulation by methylation 
(Kollmann et al., 2005).
With respect to posttranslational modifications, phospho-
relay systems are probably the most commonly used during 
evolution (Alm et al., 2006) and are found in both prokaryotic 
and eukaryotic systems. In prokaryotes, histidine and aspar-
tic acid-phosphotransfer systems dominate, whereas serine, 
threonine, and tyrosine kinases are rarely found. The opposite 
holds for eukaryotic phosphorylation cascades that primarily 
involve serine/theonine or tyrosine kinases. It is worth men-
tioning that histidine/aspartic acid-kinases mainly transfer the 
phosphoryl group to only one protein, whereas serine/threo-
nine and tyrosine kinases can phosphorylate multiple proteins. 
This might explain why in bacteria there is less feedback at 
the protein level, with negative feedback predominating at the 
transcriptional level (reviewed in Smits et al., 2006). Further-
more, phosphorylated histidine and aspartic acid residues are 
often unstable and hydrolyze spontaneously. As a result, phos-
phatases are not always required to turn off a signal in bacteria 
(Batchelor and Goulian, 2003). Another thing to consider is that 
the interaction between the histidine kinase and the aspartic 
acid-response protein specifically involves a three-dimensional 
folded surface. This is the opposite of serine/threonine and 
tyrosine kinases, which recognize linear unstructured motifs, 
as well. The same is true of the domains that recognize phos-
phorylated amino acids in eukaryotes (such as SH2, WW, and 
FHA). As a result, it is easier to engineer a serine, threonine, or 
tyrosine phosphorylation site in a protein, as well as a recogni-
tion site for domains that bind phosphorylated residues (Yeh 
et al., 2007).
Recently, a photolytic method to cleave peptides has been 
designed, whereby an unnatural amino acid (2-nitophenylala-
nine) is incorporated into proteins expressed in E. coli, (Peters 
et al., 2009), a method similar to earlier work based on the 
incorporation of 2-nitrophenylglycine in oocytes from the frog 
Xenopus (England et al., 1997). This tool could open the excit-
ing possibility of designing autoinhibited proteins, which could 
be photoactivated by cleaving off one domain. Light-induced 
activation of signaling is clearly an exciting field and one that 
could develop into new applications. Thinking further, one 
might be able to develop a system that uses the emission of 
green fluorescent protein as a source of light, which would 
open the possibility of engineering more complicated regula-
tory circuits.
Competition
After the recent avalanche of high-throughput protein-protein 
interaction data sets, many proteins are found to interact with 
a very high number of binding partners. It is evident that many 
of these interactions cannot happen simultaneously and that 
spatial and temporal aspects are needed to curate these large 
scale networks. Thus, a new field is emerging, aiming to under-
stand network properties and their underlying principles using 
structure-based design of signaling pathways (see Kim et al., 
2006; reviewed in Campagna et al., 2008, and Kiel et al., 2008). 
Structural information can be used to determine whether 
a protein can interact with two partner proteins at the same 
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time (“compatible interaction”) or not (“exclusive interaction”) 
by examining protein complex interfaces. One could imagine 
rewiring signal transduction pathways by modifying the relative 
affinity of compatible and exclusive binding sites, using struc-
ture-based design or by selectively blocking one binding site. 
Alternatively, overexpression of one partner could block one 
of the branches in a signal transduction pathway. Again, the 
limitations of this method are the availability of X-ray structures 
of the complexes and reliable protein design tools.
Degradation
Another mechanism to achieve a dynamic response and a 
quick adaptation to signals (aside from fast phosphorylation 
and dephosphorylation) is the ability to control the half-life of 
proteins by proteolysis or degradation. Eukaryotes mainly use 
ubiquitin as a molecule to target proteins for destruction, which 
allows very complex regulation involving multiple proteins 
ensuring the specificity of ubiquitination. Bacteria also contain 
complex degradation machineries, and the regulators of signal 
transduction are usually unstable proteins (reviewed in Jenal 
and Hengge-Aronis, 2003). However, no system analog to ubiq-
uitin has being found so far and degradation of proteins follows 
simpler rules such as the identity of the N-terminal amino acid 
or some sequence specific signals. Tunable degradation (for 
example, phosphorylation dependent) has been successfully 
developed in yeast and bacteria and is therefore expected to 
be a valuable tool for both prokaryotes and eukaryotes (McGin-
ness et al., 2006; Grilly et al., 2007).
Groups have taken advantage of our increasing knowledge 
in protein degradation as a tool for engineering signaling path-
ways. For example, a specific heterobifunctional small mole-
cule, called PROTAC (proteolysis-targeting chimeric molecule), 
induces ubiquitin-dependent proteolysis that targets a given 
protein for degradation in a controlled manner and timing 
(Sakamoto et al., 2001). Protac1 is a chimeric molecule that 
can simultaneously bind the target protein (in this case, methi-
onine aminopeptidase-2) and the F-box protein β-TRCP as part 
of the ubiquitin ligase complex, and thus Protac1 induces ubiq-
uitination and degradation of the target protein.
Diffusion and Transport
In general, the topology and regulation of signal transduc-
tion networks are largely distinct in eukaryotes and prokary-
otes. The different cell size and the existence of a nuclear 
membrane that isolates the genetic material and delays the 
responses in eukaryotes, as well as the uncoupling of tran-
scription-translation, have profound effects on the efficiency 
of signal propagation. Therefore, signaling cascades are 
usually longer in eukaryotes where the increased number of 
intermediates, exemplified by the mitogen-activated protein 
kinase (MAPK) pathways, presumably plays a role in signal 
amplification and in the reduction of input noise (Mayawala 
et al., 2004). As a result, in many cases, the system cannot 
rely on diffusion to transmit a signal; it needs active transport 
that is ensured by the cytoskeleton and molecular motors. 
Prokaryotes, on the other hand, because of their small vol-
ume, can rely on diffusion as the way to transmit the signal, 
although there are exceptions, such as the Min system (Mein-
hardt and de Boer, 2001), which localizes proteins to the divi-
sion plane in cell division.
Feedback Regulation and Computational Modeling
In both prokaryotes and eukaryotes, robustness is achieved 
by negative and positive feedback regulation (Kollmann et al., 
2005; Ferrell, 2008). The smaller size in general of protein phos-
phorylation cascades in bacteria, as well as the smaller degree 
of amplification requires fewer safeguards against spontane-
ous activation than in eukaryotes, and thus the complexity of 
negative feedback regulation is lower. The opposite is true in 
Eukarya, and negative feedback is expected to be larger and 
occur on multiple levels. The presence of negative feedbacks 
makes it difficult in many cases to modify signaling by altering 
kinetic or equilibrium binding properties (Kitano, 2007; Kiel and 
Serrano, 2009). By combining all these molecular engineering 
techniques, we now have the capability to not only rewire sig-
naling pathways, but to control the way we rewire them. For 
instance, positive and negative feedback loops can prolong or 
shorten the output of a signaling cascade, and interconnected 
feedback loops can result in sophisticated network behaviors 
such as oscillations (for example, oscillations in the p53/MDM2 
system; see Geva-Zatorsky et al., 2006).
The presence of negative and positive feedbacks in signal 
transduction makes it difficult for the human brain to predict the 
consequences of altering or engineering the molecules of the 
network and thus requires the use of computer simulation. Even 
simple networks can show nonintuitive responses, and com-
puter simulations are essential for predicting the effect of inter-
linked positive and negative feedbacks (reviewed in Di Ventura et 
al., 2006). Powerful modeling requires information on concentra-
tion of species and rate constants for reactions. Therefore, it is 
worth stressing the necessity of having tools for acquiring rate 
constants (in vitro and in vivo) (Slaughter et al., 2007), as well 
as tools for determining absolute concentrations (Picotti et al., 
2009). Also, sensitivity analysis, which is the changing of param-
eters for reactions and concentrations, can be helpful in guiding 
experiments and finding the sensitive/crucial points in the net-
work prior to engineering (Chen et al., 2009).
Specificity and Crosstalk
There is little evidence of crosstalk in prokaryotes (Bourret, 
2008), whereas eukaryotic signaling pathways are highly com-
plex and interconnected, which is a requirement for respond-
ing to and integrating multiple signals (reviewed in Jordan 
et al., 2000). Part of the complexity in signal transduction in 
eukaryotes arises from plasticity (pathway switching), meaning 
that signals can be switched into alternative pathways, while 
achieving nearly identical outputs (Amit et al., 2007). This could 
be a problem when engineering signaling in eukaryotes as it 
is difficult to isolate the engineered circuit from the rest of the 
cell. The documented presence of scaffolds and adapters can 
be used for isolating the signal, as well as for linking the engi-
neered network to other cellular networks (reviewed in Bhat-
tacharyya et al., 2006). Scaffolds in bacteria exist in the form of 
cytoskeletal proteins, like MreB, MinCDE, and FtsZ (Vats et al., 
2009), and in the form of adaptors, such as those for targeted 
proteolysis, which improve the kinetics and specificity of sub-
strate recognition (Dougan et al., 2002).
In summary, in signaling systems, the main challenges lie 
in improving the protein design tools for rational engineering 
of protein dynamics, for allosteric conformational changes, 
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and for linker properties, such as flexibility and effective dis-
tance (that is, the distance between two domains depends 
on the linker properties and not necessary only on its length). 
Of special importance is the possibility of manipulating exist-
ing receptors so that they can either recognize molecules not 
present in the biological system, or be connected (via the cyto-
plasmic part of the receptor) to newly engineered pathways 
in a specific manner. This also requires improvements in tools 
for protein design, and a better understanding of the confor-
mational changes of receptors upon ligand binding. Simulation 
tools that are fast and take into account cell localization, dif-
fusion, and active transport, will be needed to exploit spatial 
localization in signal transduction engineering. Finally, we need 
to control the kinetic parameters of association and dissocia-
tion, in order to fine tune our engineered pathways.
Engineered Pathways in Eukaryotes and Prokaryotes
Examples of engineered signal transduction pathways can be 
separated into engineering exercises that involve modulation 
of signaling pathways (that is, changing the properties of the 
pathway), those that rewire existing signal transduction path-
ways, and those that create artificial signaling modules. In the 
following, we will discuss recent engineering work accom-
plished in both eukaryotic and prokaryotic signal transduction 
pathways.
Modulation of Signaling
When modulation is used to engineer signal transduction, one 
can distinguish between changes that selectively eliminate one 
or more particular branches in a pathway and those where the 
properties of proteins are altered, thus affecting interactions or 
half-lives of the involved proteins. Partial loss-of-function muta-
tions can be used to specifically dissect the contribution of dif-
ferent branches within a network to a particular output. This has 
been done to study the contribution of c-Raf-independent effec-
tor pathways of Ras in T cells (Czyzyk et al., 2003). Various effec-
tor proteins were expressed together with Ras mutants impaired 
in their ability to bind and activate certain Ras effectors (Figure 
3A). Improving these partial loss-of-function mutations in Ras or 
creating them for other key cellular proteins using rational pro-
tein design would provide the framework for dissecting single 
branches in the context of larger networks (“branch pruning”). In 
a recent study, growth hormone (GH) binding to its receptor was 
altered by mutagenesis (based on the X-ray structure) to deter-
mine the choice between two signaling pathways (Rowlinson et 
al., 2009). The designed growth hormone mutant shows altered 
conformational changes that induce one downstream pathway 
(Jak/STAT) but can no longer activate the other (ERK) (Figure 3B).
Cell surface receptors and ligands are often involved in dis-
ease and have been the targets of structure-based design to 
block or change binding specificity. This has been success-
Figure 3. Modulation of Signal Transduction
(A) A Ras mutant (V12, G37) that is unable to ac-
tivate the effector protein c-Raf has been used to 
study c-Raf-independent effector pathways in hu-
man T cells (Czyzyk et al., 2003).
(B) When human growth hormone (GH) is modified 
with a G120R mutation, it induces conformational 
changes in the growth hormone receptor (GHR) 
such that it can activate the Jak/STAT pathway but 
not the ERK pathway (Rowlinson et al., 2009).
(C) Using computational design, a TRAIL (tumor 
necrosis factor-related apoptosis-inducing ligand) 
mutant has been created such that it can only 
bind to the DR5 receptor, and not to TRAIL’s other 
receptors. This specificity induces faster kinetics 
of receptor activation and induction of apoptosis 
in colon carcinoma (Colo205) cells (E. Szegezdi, 
L.S., and A. Samali, unpublished data).
(D) Using structure-based design, various c-Raf mu-
tants have been made that alter the kinetics of its as-
sociation with Ras. The effect on signal transduction 
of these mutants strongly depends on the network 
topology: the effect is minor under conditions of 
strong negative feedback in human embryonic kid-
ney cells (HEK293), but a strong effect is observed 
in a cell line with reduced negative feedback (rabbit 
kidney cells, RK13) (Kiel and Serrano, 2009).
(E) A system for controllable degradation of pro-
teins has been devised in the yeast Saccharomy-
ces cerevisiae that involves the expression of a 
modified ClpXp protease from the bacterium Es-
cherichia coli. Target proteins are expressed with 
a ssrA tag, which is specifically recognized by the 
ClpXp proteasome (Grilly et al., 2007). EGFP, en-
hanced green fluorescent protein.
(F) A system for controllable protein degradation 
in E. coli also uses the ClpXp system and target 
proteins tagged to ssrA. For better control of deg-
radation, an additional feature is the inclusion of 
the adaptor protein SspB, which increases the 
efficiency of degradation, is expressed under an 
inducible promoter (McGinness et al., 2006).
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fully achieved for tumor necrosis factor (TNF) and TNF-related 
apoptosis-inducing ligand (TRAIL) signaling (van der Sloot et 
al., 2006; Tur et al., 2008; Mukai et al., 2009; Reis et al., 2009). 
In another approach, a kinetically controlled inhibition through 
prevention of heterodimerization, leads to faster kinetics of 
receptor activation and induction of apoptosis (E. Szegezdi, 
L.S., and A. Samali, unpublished data). In this case, com-
puter simulations of the activation kinetics guided the design 
of mutants that were otherwise counterintuitive (Figure 3C). In 
the above discussed design examples, the successes were 
achieved by a combination of available X-ray structures, pow-
erful design algorithms, and a bounty of prior knowledge on 
these systems.
Protein design can also be used to specifically modify 
affinities or kinetic properties of protein complexes to pro-
vide knowledge about the underlying network topologies. 
Recently, subtle mutations were designed to unveil the role of 
electrostatic interactions in the interface of the Ras-c-Raf on 
the magnitude of signal transduction stimulated by epidermal 
growth factor (EGF) (Kiel and Serrano, 2009). By a combina-
tion of experimental and modeling approaches, it was shown 
that the rate constants for the Ras-c-Raf association have a 
greater effect on signal transduction than the rate constants for 
dissociation. However, this effect is strongly cell-type specific, 
with its behavior being critically dependent on the underlying 
network topology (strong/weak negative feedback) (Figure 3D). 
Here, the success was achieved without prior knowledge of 
the system; the different underlying feedback regulation of the 
two different cell lines only became clear later, after combining 
design, simulations, and experimental tools.
The tunable degradation of a tagged protein has been 
achieved in a S. cerevisiae strain by expressing a modified E. 
coli protease (ClpXP) under the control of a repressible pro-
moter (Grilly et al., 2007) (Figure 3E). A similar technique has 
been used in baceria for engineering controllable protein deg-
radation (McGinness et al., 2006). In that case, the degradation 
system was optimized using modifications in the tag and by 
induction of the adaptor SspB, to allow better control of deg-
radation (Figure 3F).
Rewiring of Signal Transduction Pathways
The modularity of proteins involved in signal transduction 
enables domain shuffling to make chimeras with new con-
nectivity. Rewiring of signaling pathways using domains and 
peptides involved in autoinhibition has been successfully intro-
duced into N-WASP (Neural Wiskott-Aldrich syndrome protein), 
a protein that regulates actin assembly (Dueber et al., 2003). 
Figure 4. Rewiring of Signal Transduction 
Pathways
(A) Combining different guanine nucleotide ex-
change factor (GEF) domains with an artificial 
regulatory motif has been used to rewire GT-
Pase signaling. The regulatory motif consists of 
a PDZ domain and a PDZ binding motif, render-
ing the GEF inactive by autoinhibition. Activation 
is achieved by cAMP induction, PKA activation, 
and phosphorylation of the PDZ binding motif 
(Yeh et al., 2007).
(B) In RAT-2 rat fibroblasts epidermal growth 
factor (EGF) signaling has been rewired by 
fusing SH2 or PTB domains of the adaptor 
proteins Grb2 and Shc to the dead domain 
(DED) of FADD. Consequently, cell death is 
triggered after stimulation by EGF (Howard et 
al., 2003).
(C) A chimera between the light-sensing part of 
the G protein coupled receptor (GPCR) of Rho-
dopsin and two other GPCRs, the β2 and α1 
adrenergic receptors, results in light stimulated 
β2 and α1 specific cellular responses in human 
embryonic kidney (HEK293) cells and in adult 
mice (Airan et al., 2009).
(D) Light-dependent activation in the bacterium 
Escherichia coli is achieved by a chimera of a 
cyanobacterial photoreceptor (PCB) with the 
EnvZ-OmpR two-component system. The re-
porter is modified to produce a black compound, 
so E. coli cells when grown on agar, produce a 
light dependent image (“bacterial photography”) 
(Levskaya et al., 2005).
(E) Saccharomyces cerevisiae cells were engi-
neered for cell-to-cell communication with ele-
ments from the model plant Arabidopsis thali-
ana. Sender cells produced a plant cytokinin (IP), 
which could diffuse to receiver cells and bind to 
the plant receptor AtCRE1, and consequently in-
duced the yeast YPD1 signaling cascade (Chen 
and Weiss, 2005).
(F) A cell-to-cell communication system was engineered in the marine bacterium Vibrio fischeri, which produced a diffusible acyl-homoserine lac-
tone (AHL). Upon a critical cell density, AHL together with a transcriptional regulator (LuxR) induced the production of a “killer gene” (E) (You et al., 
2004).
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Autoinhibitory interactions in the natural variant of N-WASP 
involve the GTPase binding domain (GBD), and this inhibition is 
relieved after binding of the GTP-bound form of CDC42, a Rho 
family GTPase. Rewiring of this pathway is achieved by replac-
ing the relief of autoinhibition through the GBD-CDC42•GTP 
interaction with the relief of autoinhibition by a PDZ domain/
PDZ-ligand interaction. As a consequence, activation of this 
artificial N-WASP protein is achieved by increasing the amount 
of free PDZ ligand. This work has been extended in a remark-
able follow-up study, in which GTPase signaling is rewired by 
recombining catalytic guanine nucleotide exchange factors 
(GEFs) for Rho proteins with new regulatory motifs (Yeh et 
al., 2007). These synthetic RhoGEFs responded to nonnative 
inputs that ultimately evoke morphological changes in the cells 
(Figure 4A). These studies are promising because they demon-
strate a very high evolutionary plasticity of this large family of 
modular RhoGEF proteins. In another study, signal transduc-
tion by the receptor tyrosine kinase ErbB2 could be rewired by 
fusing SH2 domains of the adaptor proteins Grb2 and Shc to 
the death domain of FADD, which consequently induces cell 
death (Howard et al., 2003) (Figure 4B). Interestingly, a poten-
tial therapeutic application of this finding is that these hybrid 
adapters have the ability to selectively kill oncogenic cells.
A large body of research on yeast signaling pathways has 
demonstrated that modifying signaling can be achieved by 
changing scaffold interactions (see Harris et al, 2001; reviewed 
in Dueber et al., 2004). In one study, pathways were rewired to 
have artificial input-output properties, such that α-factor, which 
normally activates the yeast mating pathway, instead triggers 
the osmolarity response (Park et al., 2003). More recently, the 
Ste5 scaffold has been used as a platform to modify overall 
pathway kinetics and dynamics in a predictable way (Bashor et 
al., 2008). Moreover, rewiring of kinase specificities is possible 
in bacterial two-component systems. This has been accom-
plished by investigating all residues involved in binding for both 
the families and species and identifying the residues that have 
coevolved. Mutating these highly specific residues changes 
the output of the signal (Skerker et al., 2008). Other research-
ers, using computational methods, have successfully rewired 
quorum-sensing pathways and predicted outputs that could 
be confirmed experimentally (Haseltine and Arnold, 2008).
A very exciting light-dependent regulation of a signaling cas-
cade has been developed for eukaryotes (Airan et al., 2009). 
In this work, the authors generated a chimera between the 
light-sensing part of rhodopsin, a G protein-coupled recep-
tor (GPCR), and another GPCR (the β2 and the α1 adrenergic 
receptor) (Figure 4C). This was used to study β2 and α1 GPCR 
signaling in human embryonic kidney 293 cells after induc-
tion with light and to investigate light-dependent behaviors in 
adult mice. Light-dependent activation and control of protein 
phosphorylation has also been achieved in E. coli (Levskaya 
et al., 2005). In this case, cyanobacterial photoreceptor (PCB) 
was fused with the E. coli EnvZ-OmpR two-component system 
(Figure 4D). The lacZ reporter was modified to produce a black 
compound, and hence these engineered E. coli when grown on 
agar could be used for “bacterial photography.”
Inouye and colleagues were the first to create of chimeric 
chemoreceptors in E. coli (Utsumi et al., 1989). In this pioneer-
ing work, the cytoplasmic domain of the aspartate-sensing 
membrane receptor, Tar, was replaced by the C-terminal part 
of the osmosensor EnvZ, which uses OmpR as the transcrip-
tional activator. Since then, many functional chimeric recep-
tors have been built in E. coli. Among those are the chimeras 
between the E. coli aspartate receptor and the human insulin 
receptor (Moe et al., 1989), the chemoreceptor Trg and EnvZ in 
E. coli (Baumgartner et al., 1994), and the NarX sensor kinase 
and the Tar chemoreceptor in E. coli (Ward et al., 2002).
Rewiring methods can also be used to modify cell-to-cell 
communication. A recent study used synthetic networks to 
induce cell-cell communication between engineered yeast 
Figure 5. Artificial Signal Transduction and 
Cells
(A) Introduction of a minimal human p53 signal-
ing module into yeast, as a model system to study 
context independent human p53-Mdm2 interac-
tions (Di Ventura et al., 2008).
(B) In the bacterium Escherichia coli, partial arti-
ficial modules from the mevalonate pathway of 
the yeast Saccharomyces cerevisiae have been 
engineered to produce a terpenoid precursor for 
artemisinin, an antimalarial drug (Martin et al., 
2003).
(C) In the model plant Arabidopsis thaliana, a cyto-
kinin response has been coupled to an E. coli two-
component system (PhoB and OmpR) (Antunes et 
al., 2009). GFP, green fluorescent protein.
(D) Transplantation of the genome of Mycoplasma 
mycoides into M. capricolum, via cloning of the M. 
mycoides genome as a yeast centromeric plasmid. 
This opens the possibility of engineering a bacte-
rial genome in yeast, before transplanting in into 
the host bacterium (Lartigue et al., 2009).
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cells (Chen and Weiss, 2005). Here, “sender” cells synthe-
size a plant cytokinin, isopentyladenine (IP), which diffuses to 
neighboring receiver cells, that the plant IP receptor AtCRE1 
(Figure 4E). Upon binding of IP, the activated receptor phos-
phorylates the yeast response regulator YPD1, further down-
stream proteins of this signaling cascade, and ultimately tran-
scription is activated (and GFP production). Interestingly, both 
sender and receiver cells contained signaling elements from 
the model plant Arabidopsis thaliana. In another exercise in the 
design of cell-to-cell communication systems (in this case in 
the marine bacterium Vibrio fischeri), gene expression changes 
were coupled to cell survival or cell death, which allows for 
control of the population dynamics by “regulated killing” (You 
et al., 2004). Here, a diffusible acyl-homoserine lactone (AHL) 
is synthesized by the LuxI protein (Figure 4F). With increas-
ing cell density AHL accumulates in the cytosol and binds to 
the LuxR transcriptional regulator, which in turn leads to the 
production of a killer gene (E). In another example, a directed 
evolution procedure has been applied to the quorum-sensing 
response (Collins et al., 2006). Here, the sensitivity of different 
chemoatractants is altered by dual positive-negative selection, 
tackling two goals: the stabilization of a desired interaction and 
the destabilization of the other.
Artificial Signaling Networks and Cells
One aim in synthetic biology is to build synthetic pathways that 
do not crosstalk with the endogenous machinery, and, ulti-
mately, to create completely artificial cells. This can be done 
at two levels: (1) by transplanting whole pathways from other 
organisms, thus in principle minimizing crosstalk, and (2) by 
engineering different proteins in order to create de novo path-
ways designed to minimize context effects. The first steps 
toward complete artificial networks have been achieved by the 
successful introduction of a higher eukaryotic p53 signaling 
module into yeast (Di Ventura et al., 2008) (Figure 5A). The aim 
of this work was to study p53-Mdm2 functional interactions, in 
the absence of other functional regulators in the p53 signaling 
pathways. Therefore, the authors have chosen to analyze these 
interactions in yeast as a model organism, given that many 
regulators are missing in this system. Partial artificial modules 
have been created in the field of biotechnology, such as that for 
artemisinin biosynthesis, by exporting the precursor synthesis 
pathway from S. cerevisiae to E. coli (Martin et al., 2003) (Figure 
5B). Moreover, the interkingdom transfer of signaling modules 
has been accomplished for the two-component systems from 
plants to bacteria (Antunes et al., 2009) (Figure 5C) and vice 
versa (Suzuki et al., 2001). The above examples suggest that in 
the future it may be possible to transplant full pathways from 
one species to another while preserving functionality. Progress 
can also be expected toward the assembly of fully artificial 
organelles, which would independently perform their functions 
in the cytosol (Purnick and Weiss, 2009).
Currently, computational tools provide a new array of pos-
sibilities for protein engineering, such as computer-designed 
receptor variants for pre-existing ligands (Looger et al., 2003). 
This approach has also been used to convert a ribose-bind-
ing protein into a receptor for extracellular Zn2+, which in turn 
could be coupled to the activation of a target gene (Dwyer et 
al., 2003). Eventually, we will be able to design signaling motifs 
and domains with the desired structure, which has been shown 
for a small protein (Kuhlman et al., 2003) or for a new enzyme 
(Jiang et al., 2008), allowing synthetic biologists to build new 
artificial circuits that will not interfere with the endogenous net-
work. The number of possibilities could be further expanded 
by using nonnatural amino acids. For example, orthogonal 
aminoacyl-tRNA synthetases and tRNA suppressors have 
been used to implement the genetic code with new, synthetic 
amino acids (Liu et al., 2007), and this might open the possibil-
ity for increasing the structural variability and binding proper-
ties of proteins. For instance, one can include amino acids that 
induce the dimerization of a given protein with its binding part-
ner upon light exposure, which would be a means of controlling 
or inducing protein-protein interactions (Chin et al., 2002).
The limitation for these kinds of exercises is the problem of 
synthesizing large chromosomes or plasmids that contain mul-
tiple genes plus regulatory elements in an organism. However, 
recent advances in DNA synthesis (Gibson et al., 2008) and 
the possibility of replacing a whole bacterial chromosome with 
another (Lartigue et al., 2007; Lartigue et al., 2009) (Figure 5D) 
show that this problem may be overcome soon.
Toward Applications in Biotechnology and Medicine
There have been synthetic signaling networks that have been 
successfully designed for specific applications in biomedicine 
and industrial biotechnology, but there is still more to be done. 
Here, we describe some examples highlighting the promising 
future applications of engineered signaling pathways.
Some researchers have been engineering simple peptide 
building blocks to assemble new proteins through functional 
screening of combinatorial libraries (“motif reprogramming”; 
see Saito et al., 2007), which has proven successful in repro-
gramming cancer cells to undergo apoptosis (Saito et al., 
2004). In addition, the use of synthetic intracellular antibodies 
(“intrabodies”; see Lobato and Rabbitts, 2003) could lead to an 
unlimited battery of surfaces for protein-protein interactions. 
For example, single-domain antibody fragments have proven 
useful in preventing Ras signaling in oncogenic cells (Tanaka 
et al., 2007) and could potentially set the basis for macromol-
ecule-based drugs in cancer therapy. A different approach is 
exemplifid by an engineered strain of the pathogenic bacte-
rium Yersinina sp. that can sense the microenvironment of a 
tumor and invade cancer cells (Anderson et al., 2006). Simi-
larly, attenuated Salmonella strains have been engineered to 
target malignant cells (reviewed in Bermudes et al., 2002). In 
the future, these bacteria might also be used as vehicles for 
drug delivery. A synthetic network introduced into mammalian 
cells has been used to evaluate sensitivity to an antituberculo-
sis drug (Weber et al., 2008). With further developments, this 
could become a system that aids in drug discovery.
In another exciting approach, programmable cells have been 
constructed using combinations of synthetic gene networks 
and regulatory cellular circuits (Kobayashi et al., 2004). In this 
work, the engineered bacterial strains act as whole-cell biosen-
sors—that is, one strain stores a detection event for later inter-
rogation, while another strain expresses a target gene upon 
reaching a critical cell density. Security agencies have also 
found applications of bacterial signaling. For instance, a syn-
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thetic signal transduction pathway regulating gene expression 
has been engineered so that it could function as a biosensor 
for new ligands, which could have applications for the detec-
tion of biological or chemical hazards (Looger et al., 2003). This 
system was based on a computational engineering approach, 
with the designed receptor acquiring the capacity to bind new 
ligands such as trinitrotoluene, l-lactate, or serotonin with high 
selectivity and affinity.
Programmed pattern formation and engineering of complex 
behaviors is a first step toward tissue engineering (see reviews 
by Sia et al., 2007, and Purnick and Weiss, 2009). Currently, 
designed systems have succeeded in producing programmed 
multicellular pattern formation (Basu et al., 2005). Future prog-
ress in pattern formation and tissue engineering will primarily 
depend on the creation and modification of circuits for cell-to-
cell communication (Brenner et al., 2007). Another important 
application for industrial biotechnology might be engineering 
plant signal transduction (reviewed in Bowen et al., 2008). For 
example, in an exciting approach, a synthetic circuit allows 
chlorophyll levels to be placed under the control of a specific 
input (Antunes et al., 2006).
Conclusions and Outlook
In principle, in order to create fully artificial living systems that 
are able to respond to their environment, evolve, and reproduce, 
we first need a deep level of understanding of how cells work. 
However, we are still far away from reaching this goal. Sys-
tems biology has contributed significantly by uncovering many 
general systems properties, such as feedback regulation and 
noise. Further, large-scale experiments have revealed genetic 
and protein interaction networks in different organisms. How-
ever, our understanding is incomplete concerning the cellular 
functions and regulation of all proteins, and how cells adapt to 
a different environments. Even for a small bacterium like Myco-
plasma pneumoniae, a full analysis of protein-protein interac-
tions, gene expression, and metabolism (Güell et al., 2009; 
Kühner et al., 2009; Yus et al., 2009) reveals greater complexity 
than previously thought. For example, the promiscuity of many 
protein interactions and crosstalk between signaling pathways 
makes it difficult to engineer highly specific interactions. This 
could be minimized by using modules or proteins from other 
species, but this does not guarantee spurious interactions (for 
instance, the expression of Abl or Src kinases in yeast is toxic; 
see Trager and Martin, 1997, and Seeliger et al., 2005). Finally, 
the lack of knowledge in regards localization signals, degrada-
tion mechanisms, and protein turnover are drawbacks for full 
automatization and success of engineering projects.
In spite of this, engineering has been successful in both 
prokaryotes and eukaryotes. Engineering in prokaryotes has 
been dominated by rewiring of two-component systems and 
the generation of chimeric receptors. In eukaryotes, rewiring 
strategies are mainly based on domain shuffling or using chi-
meric receptors with scaffolds rewiring being a very prominent 
engineering tool. The main conclusion from all of these exam-
ples is that crosstalk does not appear to be a major problem 
as has been feared. However, a general lack of understanding 
of negative feedback regulation could create problems, given 
that such regulation could dampen desired signaling outcomes 
in engineered systems (Kiel and Serrano, 2009). Thus, in the 
same way that we are able to engineer proteins provided that 
we have a structure even when we do not yet understand how it 
folds, it appears that we can engineer living systems provided 
that we understand the basic features of how they are orga-
nized and regulated.
Another problem that could hamper engineering of signaling 
pathways is the unique characteristics of proteins and domains 
that makes them difficult to engineer and extrapolate from one 
to another (for example, an SH3 domain can be folded on its own 
in many instances, but in some cases it will be fully unfolded; 
see Northey et al., 2002). Similarly, folding and aggregation 
issues when fusing domains from different proteins or spurious 
cell localization signals could hamper engineering of signaling 
pathways. Beyond these biological obstacles, there are other 
limitations, including the design of suitable linkers when shuf-
fling domains, the efficient transformation and tight and con-
trolled regulation of the expression of engineered proteins, and 
the inherent stochasticity and variability found in cells (Sigal et 
al., 2006). However, in practical terms, groups have found that 
domain reshuffling works very well in many systems. In respect 
to evolution, this clearly makes sense: multidomain proteins 
with rewired functionalities, and changed input-output behav-
iors, can be generated easily (and with not too many trials on 
optimal domain boundaries). Similarly, it seems that it is not 
difficult to find the right length of a linker, and neither aggre-
gation nor misfolding has been reported as a major obstacle. 
Thus, improving algorithms for protein design to include pro-
tein flexibility and large conformational changes and the design 
of selections systems with directed evolution seems to be the 
main limitation at the moment.
To tackle these issues, we will need to correctly identify 
proteins, domains, and interaction modules that behave in a 
robust and predictive manner to allow for assembly in differ-
ent combinations. The success of engineering signal trans-
duction pathways, and whether it will become a discipline like 
DNA engineering, will greatly depend on how many reliable 
standardized parts we can generate and how we can mini-
mize context effects (such as going from a neuron to a muscle 
cell). Finally, aside from manipulating phosphorylation sig-
nals, it is expected that we will also witness the harnessing of 
signaling through second messengers [such as AppppA, (p)
ppGpp, cAMP, and Ca2+] and other posttranslational modifi-
cations (such as acetylation or methylation). The combination 
of modules that can respond to these molecules or new ones 
engineered to recognize synthetic molecules (for example, the 
engineering of artifical receptors; reviewed in Mathonet and 
Fastrez, 2004), with classical phosphorylation relays, will lead 
the way to more complex designs and behaviors.
The examples we have discussed above suggest that in 
principle many of the possible hurdles and problems one could 
predict to hamper synthetic biology are probably smaller than 
we thought. Even the limitation of making small chromosomes 
is on its way to being solved by new DNA synthesis capabili-
ties. Perhaps the biggest challenge at the moment is to have 
a large collection of well-characterized protein modules that 
could be used for building new protein networks. We need 
modules that can be activated selectively by small molecules 
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that can diffuse through the membrane, or by other external 
perturbations (such as light, temperature, and pH). Also, we 
require modules that can undergo allosteric conformational 
changes in a controlled way, so that hidden surfaces can be 
exposed in a controlled manner to allow localization or inter-
action with other proteins. Furthermore, we need linear motifs 
that can be postranslationally modified and then recognized 
in a highly specific manner by other modules. In addition, it is 
necessary to have more scaffolds, which could help insulate 
signals, and, more importantly, we need to have large reposi-
tories with all the information of these modules connected to 
tools for network simulation, so that one could work like an 
engineer designing a new machine. Of course, on top of this, 
we require a good knowledge of the system to be engineered, 
but this does not need to be exhaustive at least for many bio-
technological applications.
There have been many discussions on whether there is a 
limitation to what we can learn about biology. Although there 
will always be something new to learn about biological sys-
tems, like other disciplines of science, the pace of discovery 
may eventually slow down. On the other hand, provided that 
we have the tools, the engineering of living systems appears to 
be limited only by our imagination.
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